477 related articles for article (PubMed ID: 25763579)
1. Investigation of occult hepatitis B virus infection in anti-hbc positive patients from a liver clinic.
Martinez MC; Kok CC; Baleriola C; Robertson P; Rawlinson WD
PLoS One; 2015; 10(3):e0117275. PubMed ID: 25763579
[TBL] [Abstract][Full Text] [Related]
2. Occult hepatitis B virus infection with positive hepatitis B e antigen.
Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
[TBL] [Abstract][Full Text] [Related]
3. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
[TBL] [Abstract][Full Text] [Related]
4. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera.
Chongsrisawat V; Thawornsuk N; Theamboonlers A; Louisirirotchanakul S; Poovorawan Y
Viral Immunol; 2006; 19(4):623-9. PubMed ID: 17201657
[TBL] [Abstract][Full Text] [Related]
6. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
Coffin CS; Mulrooney-Cousins PM; Osiowy C; van der Meer F; Nishikawa S; Michalak TI; van Marle G; Gill MJ
J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
[TBL] [Abstract][Full Text] [Related]
7. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
[TBL] [Abstract][Full Text] [Related]
8. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
Launay O; Masurel J; Servant-Delmas A; Basse-Guérineau AL; Méritet JF; Laperche S; Sogni P; Rosenberg AR
J Viral Hepat; 2011 Oct; 18(10):721-9. PubMed ID: 21914087
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B virus infection: influence of S protein variants.
Zhang Z; Zhang L; Dai Y; Zhang Y; Li J; Li X
Virol J; 2016 Jan; 13():10. PubMed ID: 26786229
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
Kang SY; Kim MH; Lee WI
Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
[TBL] [Abstract][Full Text] [Related]
12. Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil.
Almeida RW; Mello FCDA; Menegoy IV; Santo MPDE; Ginuíno CF; Sousa PSF; Villar LM; Lampe E; Lewis-Ximenez LL
Mem Inst Oswaldo Cruz; 2017 Jul; 112(7):485-491. PubMed ID: 28591309
[TBL] [Abstract][Full Text] [Related]
13. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
14. T cell responses and viral variability in blood donation candidates with occult hepatitis B infection.
Bes M; Vargas V; Piron M; Casamitjana N; Esteban JI; Vilanova N; Pinacho A; Quer J; Puig L; Guardia J; Sauleda S
J Hepatol; 2012 Apr; 56(4):765-74. PubMed ID: 22173156
[TBL] [Abstract][Full Text] [Related]
15. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
Aydın N; Kırdar S; Uzun N; Eyigör M; Sayan M
Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study.
Mardian Y; Yano Y; Wasityastuti W; Ratnasari N; Liang Y; Putri WA; Triyono T; Hayashi Y
Virol J; 2017 Oct; 14(1):201. PubMed ID: 29061159
[TBL] [Abstract][Full Text] [Related]
17. Occult HBV among Anti-HBc Alone: Mutation Analysis of an HBV Surface Gene and Pre-S Gene.
Kim MH; Kang SY; Lee WI
Yonsei Med J; 2017 May; 58(3):557-563. PubMed ID: 28332361
[TBL] [Abstract][Full Text] [Related]
18. A new vaccine escape mutant of hepatitis B virus causes occult infection.
Ye Q; Shang SQ; Li W
Hum Vaccin Immunother; 2015; 11(2):407-10. PubMed ID: 25692622
[TBL] [Abstract][Full Text] [Related]
19. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
[TBL] [Abstract][Full Text] [Related]
20. Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.
Vargas JI; Jensen D; Sarmiento V; Peirano F; Acuña P; Fuster F; Soto S; Ahumada R; Huilcaman M; Bruna M; Jensen W; Fuster F
J Med Virol; 2016 Apr; 88(4):639-46. PubMed ID: 26381185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]